Attached files
file | filename |
---|---|
10-K - BIOMIMETIC THERAPEUTICS, INC. | v176821_10k.htm |
EX-32.2 - BIOMIMETIC THERAPEUTICS, INC. | v176821_ex32-2.htm |
EX-31.2 - BIOMIMETIC THERAPEUTICS, INC. | v176821_ex31-2.htm |
EX-23.1 - BIOMIMETIC THERAPEUTICS, INC. | v176821_ex23-1.htm |
EX-31.1 - BIOMIMETIC THERAPEUTICS, INC. | v176821_ex31-1.htm |
EX-21.1 - BIOMIMETIC THERAPEUTICS, INC. | v176821_ex21-1.htm |
EX-10.57 - BIOMIMETIC THERAPEUTICS, INC. | v176821_ex10-57.htm |
EX-10.56 - BIOMIMETIC THERAPEUTICS, INC. | v176821_ex10-56.htm |
EXHIBIT
32.1
CERTIFICATION
In
connection with the Annual Report of BioMimetic Therapeutics, Inc. (the
“Company”) on Form 10-K for the period ended December 31, 2009 as filed with the
Securities and Exchange Commission (the “Report”), I, Dr. Samuel E. Lynch, Chief
Executive Officer and President of the Company, hereby certify as of the date
hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United
States Code, that to the best of my knowledge:
1.
|
The
Report fully complies with the requirements of Section 13(a) or 15(d), as
applicable, of the Securities Exchange Act of 1934, as amended;
and
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company
at the dates and for the periods
indicated.
|
This
Certification has not been, and shall not be deemed, “filed” with the Securities
and Exchange Commission.
Date:
March 12, 2010
/s/
Samuel E. Lynch
Dr.
Samuel E. Lynch
Chief
Executive Officer and President